SURGICAL INNOVATIONS GROUP PLC (SUN) — Interim results for the six months ended 30 June 2025

Investor webinar replay

Replay transcript excerpt

Good morning, and welcome to the Surgical Innovations Group PLC Interim Results Investor Presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged, and they can be submitted at any time using the Q and A tab situated on or right hand corner of your screen. Simply type in your questions and press send. The company may not be in a position to answer every question received during the meeting itself. However, the company can view your questions submitted today and publish responses, which is appropriate to do so. Before we begin, I would like to submit the following poll. And I would now like to hand you over to CEO David Marsh. Good morning to you. Good morning. Good morning, everybody. I'm obviously here with Brent, our CFO, and thank you for taking the time to join us on this IMC. If we start by just looking at some of the sorry. Sorry. If we start by looking at the commercial and operations for the first half of the year, the most significant thing that we achieved in the first half of the year and more recently is the successful transition to MDR. For those of you that are unaware, the medical device regulatory bodies have moved from CE Mark to MDR, and this has been a major task for the company to achieve. So we are now recommended for certification in all of our product groups and our q m QMS as well. So this is, as I said, it's it's a major achievement and it allows the company to focus forward looking rather than spending a lot of time and bandwidth on achieving MDR. I will talk a lot about it during the presentation because we are rightly proud of having achieved that. On other in other areas, we introduced an operational improvement plan during the during 2024 where we restructured the benefit sorry, ...